Approval marks milestone for AI use in frontline care More: Nice recommends first AI medical device for skin cancer diagnosis in the NHS Source: News
read moreEli Lilly CEO Dave Ricks is joining a growing number of pharma chiefs calling for tax reform, not tariffs, to bolster U.S. investments. More: Lilly CEO urges Trump admin to 'level the playing field' by negotiating trade deals, striking down
read moreAfter BridgeBio’s ATTR-CM drug Attruby blew away analyst projections on Wednesday, Alnylam countered with positive news as well for its Amvuttra. More: Alnylam's move into ATTR-CM with Amvuttra is a 'category growth story,' CEO says Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals